Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Dongbao Bio-Tech(300239) the Revenue is 224.17 M (+23.83%);the EBIT is 19.12 M (+16.23%);the EPS is 0.0275 (-2.46%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.22B23.83%
----
----
EBIT
0.02B16.23%
----
----
EPS
0.02752.46%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf